F. de Vries

First name
F.
Last name
de Vries
Knapen, L. M., de Jong, R. G., Driessen, J. H., Keulemans, Y. C., van Erp, N. P., De Bruin, M. L., et al. (2017). Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12833
De Jong, H. J. I., van Staa, T. P., Lalmohamed, A., de Vries, F., Vandebriel, R. J., Van Loveren, H., et al. (2017). Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2016-210936
Driessen, J. H., van den Bergh, J. P., van Onzenoort, H. A., Henry, R. M., Leufkens, H. G., & de Vries, F. (2017). Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12843
Klop, C., van Staa, T. P., Cooper, C., Harvey, N. C., & de Vries, F. (2017). The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity. Osteoporos Int. http://doi.org/10.1007/s00198-016-3787-0
But, A., De Bruin, M. L., Bazelier, M. T., Hjellvik, V., Andersen, M., Auvinen, A., et al. (2017). Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study. Diabetologia. http://doi.org/10.1007/s00125-017-4312-5
Williams, R., de Vries, F., Kothny, W., Serban, C., Lopez-Leon, S., Chu, C., & Schlienger, R. (2017). Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12951
Oshagbemi, O. A., Keene, S. J., Driessen, J. H. M., Jordan, R., Wouters, E. F. M., de Boer, A., et al. (2018). Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013. Respir Med. http://doi.org/10.1016/j.rmed.2018.09.010
Keyany, A., Nielen, J. T. H., Souverein, P. C., de Vries, F., & van den Bemt, B. (2018). Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study. Diabetes Res Clin Pract. http://doi.org/10.1016/j.diabres.2018.02.010
Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., et al. (2018). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
van Dalem, J., Brouwers, M., Stehouwer, C. D. A., Krings, A., Klungel, O. H., Driessen, J. H. M., et al. (2018). Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13168